

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Autophagy ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SBI-0206965 |
+++
ULK2, IC50: 711 nM ULK1, IC50: 108 nM |
95% | |||||||||||||||||
| Hydroxychloroquine sulfate | ✔ | 99% | |||||||||||||||||
| Valproic acid sodium | ✔ | HDAC | 97% | ||||||||||||||||
| PFK-015 |
++
PFKFB3, IC50: 207 nM |
99%+ | |||||||||||||||||
| MRT68921 HCl |
++++
ULK2, IC50: 1.1 nM ULK1, IC50: 2.9 nM |
99%+ | |||||||||||||||||
| ROC-325 | ✔ | 99%+ | |||||||||||||||||
| Autophinib |
+++
Autophagy, IC50: 40 nM |
99% | |||||||||||||||||
| Lys05 | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Echinatin is a chalcone isolated from the Chinese herbal medicine Gancao with hepatoprotective and anti-inflammatory effects[3]. Administration of echinatin obviously inhibits NLRP3 inflammasome activation and ameliorates LPS-induced septic shock and dextran sodium sulfate-induced (DSS-induced) colitis in mice. Moreover, echinatin exerted favorable pharmacological effects on liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis (NASH)[4]. Echinatin induced apoptosis and autophagy through inactivation of AKT/mTOR signaling pathway, whereas constitutive activation of AKT significantly abrogated these effects. Furthermore, echinatin had a significant antitumor effect in the tumor xenograft model and markedly suppressed cell migration and invasion abilities of ESCC (Esophageal squamous cell carcinoma) cells in a dose-dependent manner[5]. Echinatin exerted its protective effect against MI/R (myocardial ischemic/reperfusion) injury at least partially by suppressing the Hippo/YAP signaling pathway[6]. Echinatin mitigates H2O2-induced oxidative damage and apoptosis in HLECs (Human lens epithelial B3 cells) via the Nrf2/HO-1 pathway, suggesting that Ech may be a potential drug for the treatment of cataracts[7]. |
| Concentration | Treated Time | Description | References | |
| THP-1 macrophages | 10 μM | 48 hours | To evaluate the anti-inflammatory activity of Q-14 compounds. Echinatin demonstrated the most robust anti-inflammation activities (inhibition rate > 90%). | Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2301775120 |
| human liver microsomes | 25.86 μM | 3 min or 33 min preincubation | To evaluate the inhibitory effect of Echinatin on CYP3A, results showed that Echinatin inhibited CYP3A-catalyzed testosterone 6β-hydroxylation in a time-dependent manner, with IC50 values decreasing from 25.86 μM to 8.08 μM. | Acta Pharmacol Sin. 2022 Apr;43(4):1072-1081 |
| Calu-3 cells | 1.1, 3.3, 10, 30 μM | 48 hours | To evaluate the inhibition effect of Echinatin on SARS-CoV-2-triggered inflammation. Echinatin reduced SARS-CoV-2-induced IL-1β P17 release in a dose-dependent manner. | Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2301775120 |
| KYSE270 cells | 10 μM, 20 μM, 40 μM | 24 h and 48 h | To evaluate the effect of echinatin on ESCC cell apoptosis, the results showed that echinatin-induced apoptosis in a dose-dependent way. | Cell Death Dis. 2020 Jul 13;11(7):524 |
| KYSE30 cells | 10 μM, 20 μM, 40 μM | 24 h and 48 h | To evaluate the effect of echinatin on ESCC cell apoptosis, the results showed that echinatin-induced apoptosis in a dose-dependent way. | Cell Death Dis. 2020 Jul 13;11(7):524 |
| KYSE270 cells | 10 μM, 20 μM, 40 μM | 5 days | To evaluate the effect of echinatin on ESCC cell proliferation, the results showed that echinatin inhibited cell proliferation substantially in both dose- and time-dependent manner. | Cell Death Dis. 2020 Jul 13;11(7):524 |
| KYSE30 cells | 10 μM, 20 μM, 40 μM | 5 days | To evaluate the effect of echinatin on ESCC cell proliferation, the results showed that echinatin inhibited cell proliferation substantially in both dose- and time-dependent manner. | Cell Death Dis. 2020 Jul 13;11(7):524 |
| mouse bone marrow-derived macrophages (BMDMs) | below 100 μM | 60 minutes | To evaluate the effect of Echinatin on NLRP3 inflammasome activation, results showed that Echinatin significantly inhibited nigericin-induced caspase-1 activation, IL-1β maturation, and LDH release. | JCI Insight. 2021 Jan 25;6(2):e134601 |
| LO2 cells | 0, 20, 30, 40, 50 μM | 24, 48, 72 hours | To evaluate the toxicity of Echinatin on normal human cells, the results showed that Echinatin had no significant toxicity on LO2 cells | Genes Dis. 2023 May 18;11(2):1050-1065 |
| HS5 cells | 0, 20, 30, 40, 50 μM | 24, 48, 72 hours | To evaluate the toxicity of Echinatin on normal human cells, the results showed that Echinatin had no significant toxicity on HS5 cells | Genes Dis. 2023 May 18;11(2):1050-1065 |
| HEB cells | 0, 20, 30, 40, 50 μM | 24, 48, 72 hours | To evaluate the toxicity of Echinatin on normal human cells, the results showed that Echinatin had no significant toxicity on HEB cells | Genes Dis. 2023 May 18;11(2):1050-1065 |
| SV-HUC-1 cells | 0, 20, 30, 40, 50 μM | 24, 48, 72 hours | To evaluate the toxicity of Echinatin on normal human cells, the results showed that Echinatin had no significant toxicity on SV-HUC-1 cells | Genes Dis. 2023 May 18;11(2):1050-1065 |
| EJ cells | 0, 20, 30, 40, 50 μM | 24, 48, 72 hours | To evaluate the inhibitory effect of Echinatin on the proliferation of bladder cancer cells, the results showed that Echinatin significantly inhibited the proliferation of T24 and EJ cells | Genes Dis. 2023 May 18;11(2):1050-1065 |
| T24 cells | 0, 20, 30, 40, 50 μM | 24, 48, 72 hours | To evaluate the inhibitory effect of Echinatin on the proliferation of bladder cancer cells, the results showed that Echinatin significantly inhibited the proliferation of T24 and EJ cells | Genes Dis. 2023 May 18;11(2):1050-1065 |
| MCF-7 | >100 μM | 48 hours | Evaluated for cytotoxicity, results showed no significant activity | Int J Mol Sci. 2021 Sep 18;22(18):10109 |
| HT-29 | >100 μM | 48 hours | Evaluated for cytotoxicity, results showed no significant activity | Int J Mol Sci. 2021 Sep 18;22(18):10109 |
| A375P | >100 μM | 48 hours | Evaluated for cytotoxicity, results showed no significant activity | Int J Mol Sci. 2021 Sep 18;22(18):10109 |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | KYSE270-derived tumor xenograft model | Oral administration | 20 mg/kg and 50 mg/kg | Every 2 days | To evaluate the inhibitory effect of echinatin on ESCC tumor growth, the results showed that echinatin significantly suppressed tumor growth without obvious toxicity to animals. | Cell Death Dis. 2020 Jul 13;11(7):524 |
| C57BL/6 mice | LPS-induced septic shock model | Intraperitoneal injection | 20 mg/kg and 40 mg/kg | Single dose | To evaluate the protective effect of Echinatin on LPS-induced septic shock, results showed that Echinatin significantly reduced the levels of IL-1β and TNF-α in serum and improved the survival rate of mice. | JCI Insight. 2021 Jan 25;6(2):e134601 |
| BALB/c nude mice | Bladder cancer xenograft model | Oral gavage | 0, 20, 40, 60 mg/kg | Once every two days for 21 days | To evaluate the inhibitory effect of Echinatin on tumor growth in a bladder cancer xenograft model, the results showed that Echinatin significantly inhibited tumor growth | Genes Dis. 2023 May 18;11(2):1050-1065 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.70mL 0.74mL 0.37mL |
18.50mL 3.70mL 1.85mL |
37.00mL 7.40mL 3.70mL |
|
| CAS号 | 34221-41-5 |
| 分子式 | C16H14O4 |
| 分子量 | 270.28 |
| SMILES Code | O=C(C1=CC=C(O)C=C1)/C=C/C2=CC=C(O)C=C2OC |
| MDL No. | MFCD00075719 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | QJKMIJNRNRLQSS-WEVVVXLNSA-N |
| Pubchem ID | 6442675 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(443.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1